Biliary Tract Neoplasms Recruiting Phase 2 Trials for Durvalumab (DB11714)

Also known as: Biliary Tract Neoplasm / Neoplasm biliary tract / Biliary neoplasm NOS / Biliary neoplasm / Neoplasm of biliary tract (disorder) / Biliary neoplasia

IndicationStatusPhase
DBCOND0032430 (Biliary Tract Neoplasms)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05935579Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract CancerTreatment